Foreign body response to synthetic polymer biomaterials and the role of adaptive immunity.

Themis R Kyriakides, Hyun-Je Kim, Christy Zheng, Lauren Harkins, Wanyun Tao, Emily Deschenes

Biomedical materials (Bristol, England) 2022 Mar 04

filter terms:

Implanted biomaterials elicit a series of distinct immune and repair-like responses that are collectively known as the foreign body reaction (FBR). These include processes involving innate immune inflammatory cells and wound repair cells that contribute to the encapsulation of biomaterials with a dense collagenous and largely avascular capsule. Numerous studies have shown that the early phase is dominated by macrophages that fuse to form foreign body giant cells that are considered a hallmark of the FBR. With the advent of more precise cell characterization techniques, specific macrophage subsets have been identified and linked to more or less favorable outcomes. Moreover, studies comparing synthetic- and natural-based polymer biomaterials have allowed the identification of macrophage subtypes that distinguish between fibrotic and regenerative responses. More recently, cells associated with adaptive immunity have been shown to participate in the FBR to synthetic polymers. This suggests the existence of cross-talk between innate and adaptive immune cells that depends on the nature of the implants. However, the exact participation of adaptive immune cells, such as T and B cells, remains unclear. In fact, contradictory studies suggest either the independence or dependence of the FBR on these cells. Here, we review the evidence for the involvement of adaptive immunity in the FBR to synthetic polymers with a focus on cellular and molecular components. In addition, we examine the possibility that such biomaterials induce specific antibody responses resulting in the engagement of adaptive immune cells. © 2022 IOP Publishing Ltd.

Citation

Themis R Kyriakides, Hyun-Je Kim, Christy Zheng, Lauren Harkins, Wanyun Tao, Emily Deschenes. Foreign body response to synthetic polymer biomaterials and the role of adaptive immunity. Biomedical materials (Bristol, England). 2022 Mar 04;17(2)